The Division of Pediatric Cardiology is home to some of the country's best research aimed at understanding improving the care of children and adults with CHD. A broad spectrum of research activities ranging from basic molecular research to device development are being pursued by faculty and all have garnered significant external support. Please see below to learn more about a few of our investigators and their research efforts.
Please see below to learn more about our investigators and their research efforts.
H. Scott Baldwin, MD
Dr. Baldwin’s research has concentrated on delineating the molecular basis of vascular development in the mammalian embryo as an approach to understanding the etiology of congenital heart disease. The ultimate goal of his laboratory is to exploit in utero developmental mechanisms to inform the therapies for postnatal congenital heart and vascular diseases. He is particularly focused on the role of the endocardium in ventricular trabecular and compaction as well as the role of the lymphatic system in mediating additional morbidities and mortalities of patients with CHD.
Thomas P. Doyle, MD
Dr. Doyle is currently collaborating with Dr. George Nicholson, Dr. Dana Janssen and a group of biomedical engineers in the design and development of tools, techniques, and devices tailored to fit the needs and improve outcomes of children with congenital heart disease.
Justin Godown, MD
Dr. Godown’s research focuses on database linkage strategies to expand analytic possibilities in pediatric heart failure and heart transplantation and novel approaches to expanding the availability and utilization of pediatric donor hearts. He is actively involved in multi-center research initiatives through the Pediatric Heart Transplant Society, the Pediatric Cardiomyopathy Registry, and the ACTION learning network. He serves on the Scientific Advisory Committee of the Enduring Hearts Foundation, a non-profit organization dedicated to funding pediatric heart transplantation research.
Prince J. Kannankeril, MD, MSCI
Dr. Kannankeril is Director of Clinical/Translational Research for the Division of Pediatric Cardiology at Vanderbilt, with faculty appointments in both the Vanderbilt Genetics Institute (VGI) and the Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). His research program focuses on genetic variants and their contribution to cardiovascular disease in the young, including outcomes after congenital heart disease surgery and unexplained sudden death. He established the Personalized Medicine Program in Pediatric Cardiology and also directs the murine electrophysiology lab at Vanderbilt.
George T. Nicholson, MD
Dr. Nicholson’s research interests focus on functional outcome and sequelae of interventional pediatric cardiology procedures through multi center collaboration. In addition, he works alongside Dr. Thomas Doyle, Dr. Dana Janssen and a group of biomedical engineers in the design and development of tools, techniques, and devices tailored to fit the needs and improve outcomes of children with congenital heart disease.
Jacqueline M. Shuplock, MD, MSCI
Dr. Shuplock’s clinical and research interests are in non-invasive cardiac imaging and fetal cardiology. She is currently leading a multi-center prospective study evaluating fetal myocardial strain and its associations with postnatal outcomes in fetuses diagnosed with d-transposition of the great arteries.
Jonathan H. Soslow, MD, MSCI
Dr. Soslow is a pediatric cardiologist with advanced training in pediatric cardiac imaging. His research focuses on serum and imaging biomarkers of cardiovascular disease in patients with Duchenne muscular dystrophy. He also focuses on the non-invasive diagnosis of rejection in patients after heart transplantation.